Fort Lauderdale, Fla.-based MAKO Surgical (UNKNOWN:UNKNOWN) shares were surging today on news that the company has settled its patent infringement dispute with Stanmore Implants Worldwide.
In a press release Tuesday, the robotic-surgery company announced that it has withdrawn its complaint against Stanmore and agreed to buy Stanmore's Sculptor Robotic Guidance Arm assets, including intellectual property, for a cash payment. Part and parcel of the settlement is Stanmore's agreement to stop doing business in the field of robotics -- removing a competitor to MAKO absolutely.
MAKO CEO Dr. Maurice R. Ferre, M.D., noted that acquiring Stanmore's robotics business not only removes a competitive threat to MAKO but also "improves MAKO's intellectual property position in robotically assisted orthopedic surgery."
MAKO shares are up 5.8% on the news, recently trading around $11.20.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends MAKO Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.